Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Eric Roeland

    TitleAssistant Clinical Professor
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address9500 Gilman Drive #0987
    CA La Jolla 92093
    Phone858-534-7079
    vCardDownload vCard

      Collapse Biography 
      Collapse Awards and Honors
      LiveMoore’s Annual Fundraising2011Featured Speaker
      American Society of Clinical Oncology2011Travel Scholar
      Slovenia Palliative Medicine2009International Educator
      Dickinson Foundation2008 - 2009Palliative Medicine Fellow
      San Diego Hospice, “Light Up a Life”2008Featured Speaker
      Virginia Schumann2003 - 2004Volunteer Scholarship
      University of Colorado Health Sciences Center2001Rural Scholar

      Collapse Overview 
      Collapse Overview
      Research Interests
      As an oncologist and palliative medicine physician, Dr. Roeland is committed to finding more effective solutions for improving the quality of care for cancer patients with advanced disease. He intimately understands the importance of integrating cancer treatment with optimal symptom control. He also has the unique advantage of having training in both oncology and palliative medicine. His current research is primarily focused on symptom intervention clinical trials across the entire spectrum of cancer. Ultimately, he wants to promote a new standard for cancer care – simultaneous integrated oncology and palliation.

      7/12-Present Principal Investigator, UCSD Moores Cancer Center, Supportive Oncology Trials

      A Randomized Phase II Placebo-Controlled Study of LY2495655 (Myostatin Inhibitor) in Patients with Advanced or Metastatic Pancreatic Cancer Receiving Chemotherapy

      Merck V212-011: A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy

      Single Center, Randomized, Prospective Study Evaluating Advance Care Planning and Documentation Implementing The 3 Questions™ in Initiating Advance Care Planning Between Patients and Their Chosen Healthcare Proxy vs. Traditional Advance Directives in an Outpatient Academic Palliative Medicine Clinic

      Education and Training
      Bachelor of Arts - Spanish Language, Northwestern University - 05/00
      MD - University of Colorado Health Sciences Center - 05/05
      Internal Medicine Internship & Residency - University of California San Diego - 06/08
      Hospice & Palliative Medicine Fellowship - San Diego Hospice & The Institute for Palliative Medicine - 06/09
      Hematology & Oncology Fellowship - University of California San Diego - 06/12


      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Roeland EJ, Triplett DP, Matsuno RK, Boero IJ, Hwang L, Yeung HN, Mell L, Murphy JD. Patterns of Palliative Care Consultation Among Elderly Patients With Cancer. J Natl Compr Canc Netw. 2016 Apr; 14(4):439-45. PMID: 27059192.
        View in: PubMed
      2. Roeland EJ, LeBlanc TW. Palliative chemotherapy: oxymoron or misunderstanding? BMC Palliat Care. 2016; 15(1):33. PMID: 27000049.
        View in: PubMed
      3. Ma JD, Benn M, Nelson SH, Campillo A, Heavey SF, Cramer A, Revta C, Thornberry K, Roeland EJ. Exploring the Definition of an Informed Health Care Proxy. J Palliat Med. 2016 Mar; 19(3):250-1. PMID: 26836962.
        View in: PubMed
      4. Roeland E, Ku G. Spanning the canyon between stem cell transplantation and palliative care. Hematology Am Soc Hematol Educ Program. 2015 Dec 5; 2015(1):484-9. PMID: 26637762.
        View in: PubMed
      5. Roeland E. Guiding Principles in the Management of Chemotherapy-Induced Nausea and Vomiting. Clin Adv Hematol Oncol. 2015 Oct; 13(10 Suppl 10):3-5. PMID: 26859507.
        View in: PubMed
      6. Roeland E, Schwartzberg LS, Aapro MS. Q&A. Clin Adv Hematol Oncol. 2015 Oct; 13(10 Suppl 10):12-3. PMID: 26859510.
        View in: PubMed
      7. Montross-Thomas LP, Irwin SA, Meier EA, Gallegos JV, Golshan S, Roeland E, McNeal H, Munson D, Rodseth L. Enhancing legacy in palliative care: study protocol for a randomized controlled trial of Dignity Therapy focused on positive outcomes. BMC Palliat Care. 2015; 14(1):44. PMID: 26391775.
        View in: PubMed
      8. Chang A, Roeland EJ, Atayee RS, Revta C, Ma JD. Transmucosal Immediate-Release Fentanyl for Breakthrough Cancer Pain: Opportunities and Challenges for Use in Palliative Care. J Pain Palliat Care Pharmacother. 2015 Sep; 29(3):247-60. PMID: 26368648.
        View in: PubMed
      9. Lin KJ, Ching A, Edmonds KP, Roeland EJ, Revta C, Ma JD, Atayee RS. Variable Patterns of Continuous Morphine Infusions at End of Life. J Palliat Med. 2015 Sep; 18(9):786-9. PMID: 26107143.
        View in: PubMed
      10. Langley-DeGroot M, Ma JD, Hirst J, Roeland EJ. Olanzapine in the Treatment of Refractory Nausea and Vomiting: A Case Report and Review of the Literature. J Pain Palliat Care Pharmacother. 2015 Jun; 29(2):148-52. PMID: 26095486.
        View in: PubMed
      11. Bruggeman AR, Heavey SF, Ma JD, Revta C, Roeland EJ. Lack of documentation of evidence-based prognostication in cancer patients by inpatient palliative care consultants. J Palliat Med. 2015 Apr; 18(4):382-5. PMID: 25608220.
        View in: PubMed
      12. Chan A, Cameron MC, Garden B, Boers-Doets CB, Schindler K, Epstein JB, Choi J, Beamer L, Roeland E, Russi EG, Bensadoun RJ, Teo YL, Chan RJ, Shih V, Bryce J, Raber-Durlacher J, Gerber PA, Freytes CO, Rapoport B, LeBoeuf N, Sibaud V, Lacouture ME. A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies. Support Care Cancer. 2015 Aug; 23(8):2231-44. PMID: 25564221.
        View in: PubMed
      13. Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, Mell LK, Murphy JD. Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90(1):224-30. PMID: 25195994.
        View in: PubMed
      14. Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015 May; 22(5):1716-21. PMID: 25145504.
        View in: PubMed
      15. Amin P, Roeland E, Atayee R. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain. J Pain Palliat Care Pharmacother. 2014 Sep; 28(3):233-42. PMID: 25102039.
        View in: PubMed
      16. Heavey SF, Roeland EJ, Tipps AM, Datnow B, Sicklick JK. Rapidly progressive subcutaneous metastases from gallbladder cancer: insight into a rare presentation in gastrointestinal malignancies. J Gastrointest Oncol. 2014 Aug; 5(4):E58-64. PMID: 25083307.
        View in: PubMed
      17. Yeung HN, Mitchell WM, Roeland EJ, Xu B, Mell LK, Le QT, Murphy JD. Palliative Radiation Before Hospice: The Long and the Short of It. J Pain Symptom Manage. 2014 May 10. PMID: 24819083.
        View in: PubMed
      18. Ma JD, Heavey SF, Revta C, Roeland EJ. Novel investigational biologics for the treatment of cancer cachexia. Expert Opin Biol Ther. 2014 Aug; 14(8):1113-20. PMID: 24707881.
        View in: PubMed
      19. Roeland E, Cain J, Onderdonk C, Kerr K, Mitchell W, Thornberry K. When open-ended questions don't work: the role of palliative paternalism in difficult medical decisions. J Palliat Med. 2014 Apr; 17(4):415-20. PMID: 24588626.
        View in: PubMed
      20. Wong-Sefdan I, Ale-Ali A, DeMoor PA, Martinez S, Curtin P, Lane T, Roeland E. Implementing inpatient, evidence-based, antihistamine-transfusion premedication guidelines at a single academic US hospital. J Community Support Oncol. 2014 Feb; 12(2):56-64. PMID: 24971406.
        View in: PubMed
      21. Ma JD, Horton JM, Hwang M, Atayee RS, Roeland EJ. A single-center, retrospective analysis evaluating the utilization of the opioid risk tool in opioid-treated cancer patients. J Pain Palliat Care Pharmacother. 2014 Mar; 28(1):4-9. PMID: 24417217.
        View in: PubMed
      22. Hwang M, Pirrello R, Pu M, Messer K, Roeland E. Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital. Support Care Cancer. 2013 Oct; 21(10):2817-24. PMID: 23732621.
        View in: PubMed
      23. Roeland E, Loprinzi C, Moynihan TJ, Smith TJ, Temel J. In chemotherapy for lung cancer, sometimes less is more. J Natl Compr Canc Netw. 2013 Mar 1; 11(3):232-5. PMID: 23486449.
        View in: PubMed
      24. Roeland E, Mitchell W, Elia G, Thornberry K, Herman H, Cain J, Atayee R, Bardwell W, von Gunten CF. Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 2: psychosocial concerns. J Support Oncol. 2010 Jul-Aug; 8(4):179-83. PMID: 20822037.
        View in: PubMed
      25. Roeland E, Mitchell W, Elia G, Thornberry K, Herman H, Cain J, Atayee R, Bardwell W, von Gunten CF. Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 1: Physical symptoms. J Support Oncol. 2010 May-Jun; 8(3):100-16. PMID: 20552923.
        View in: PubMed
      26. Roeland E, von Gunten CF. Current concepts in malignant bowel obstruction management. Curr Oncol Rep. 2009 Jul; 11(4):298-303. PMID: 19508835.
        View in: PubMed
      27. Roeland E. Darkness is no more. J Palliat Med. 2009 Apr; 12(4):389-90. PMID: 19327081.
        View in: PubMed
      Back to TOP